Company Tatva Chintan Pharma Chem Limited Bombay S.E.
Equities
TATVA
INE0GK401011
Specialty Chemicals
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,034 INR | -4.44% | -5.77% | -35.45% |
Business Summary
Number of employees: 608
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Phase Transfer Catalysts
34.0
%
| 980 | 22.7 % | 1,432 | 34.0 % | +46.09% |
Pharmaceutical and Agrochemical Intermediates and Other Specialty Chemicals
31.7
%
| 1,028 | 23.8 % | 1,335 | 31.7 % | +29.93% |
Structure Directing Agents
30.3
%
| 2,248 | 52.1 % | 1,276 | 30.3 % | -43.23% |
Electrolyte Salts
3.9
%
| 57 | 1.3 % | 165 | 3.9 % | +190.92% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
International
72.3
%
| 3,405 | 78.9 % | 3,042 | 72.3 % | -10.64% |
India
27.7
%
| 908 | 21.1 % | 1,167 | 27.7 % | +28.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 51 | 11/06/96 | |
Ashok Bothra
DFI | Director of Finance/CFO | - | 02/12/21 |
Chief Administrative Officer | - | 20/11/15 | |
Chief Operating Officer | - | 11/10/17 | |
Ajay Singh Rawat
CTO | Chief Tech/Sci/R&D Officer | - | 04/07/19 |
Compliance Officer | - | 16/01/22 | |
Rakesh Poonia
PRN | Corporate Officer/Principal | - | 16/11/06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 26/02/21 | |
Chief Executive Officer | 51 | 11/06/96 | |
Director/Board Member | 52 | 11/06/96 | |
Director/Board Member | 50 | 11/06/96 | |
Director/Board Member | 70 | 26/02/21 | |
Director/Board Member | 52 | 26/02/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,392,055 | 6,545,097 ( 27.98 %) | 0 | 27.98 % |
Company contact information
Tatva Chintan Pharma Chem Ltd.
GIDC Estate Plot No 502/17
393002, Ankleshwar
+91 75 7484 8533
http://www.tatvachintan.comSales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.07% | 66.31B | |
-0.29% | 48.46B | |
+21.61% | 43.27B | |
+26.72% | 27.41B | |
+9.25% | 19.26B | |
-2.14% | 16.61B | |
+9.75% | 16.58B | |
-15.01% | 14.41B | |
-30.22% | 14.02B |
- Stock Market
- Equities
- TATVA Stock
- TATVA Stock
- Company Tatva Chintan Pharma Chem Limited